Tumor necrosis factor receptor associated periodic syndrome (TRAPS). Report of two cases;TRAPS, un síndrome autoinflamatorio. Casos cínicos

Revista Medica de Chile

Volumn 134, Issue 12, 2006, Pages 1558-1561

  Alvarez Lobos, Manuel ^a,c   Hunter, Bessie ^b   Cofré, Colomba ^b   Benítez, Carlos ^a   Talesnik, Eduardo ^c   Oyarzo, Mauricio ^c   Aróstegui, Juan I ^d   Yagüe, Jordi ^d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL LUIS CALVO MACKENNA   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Amyloidosis; Cytogenetic analysis; Receptors, tumor necrosis factor, type I

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 1;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENETICS; HAPLOTYPE; HUMAN; MALE; MUTATION; PATHOLOGY; SYNDROME;

ADOLESCENT; ADULT; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HAPLOTYPES; HUMANS; MALE; MUTATION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SYNDROME;

EID: 33846483751     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hull KM, Kastner DL, Balow JE. Hereditary periodic fever. N Engl J Med 2002; 346: 1415-6.
2. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005; 17: 586-99.
3. Williamson LM, Hull D, Mehta R, Reeves WG, Robinson BH, Toghill PJ. Familial Hibernian fever. Q J Med 1982; 51: 469-80.
4. McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999; 97: 133-44.
5. Galon J, Aksentijevich I, McDermott MF, O'Shea JJ, Kastner DL. TNFRSF1A mutations and autoinflammatory syndromes. Curr Opin Immunol 2000; 12: 479-86.
6. Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM et al. The TNF receptor associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine 2002; 81: 349-68.
7. Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH et al. The tumour-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 2001; 69: 301-14.
8. Dode C, Andre M, Bienvenu T, Hausfater P, Pecheux C, Bienvenu J et al. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 2002; 46: 2181-8.
9. Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL. Tumour necrosis factor receptor-associated periodic syndrome: A novel syndrome with cutaneous manifestations. Arch Dermatol 2000; 136: 1487-94.
10. Drewe E, McDermott EM, Powell RJ. Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome. N Engl J Med 2000; 343: 1044-5.
11. Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology 2003; 42: 235-9.
12. Simon A, Bodar EJ, van der Hilst JC, van der Meer JW, Fiselier TJ, Cuppen MP, Drenth JP. Beneficial response to interleukin 1 receptor antagonist in traps. Am J Med 2004; 117: 208-10.